Thomas Suzanne E, Miller Peter M, Randall Patrick K, Book Sarah W
Center for Drug and Alcohol Programs, Charleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
J Subst Abuse Treat. 2008 Oct;35(3):260-8. doi: 10.1016/j.jsat.2007.11.001. Epub 2008 Mar 7.
Alcoholism pharmacotherapies are underused in community addiction treatment settings, in part because individuals who practice in these settings--nonmedical addiction counselors and administrators--lack knowledge about and confidence in the value of adjunctive alcohol pharmacotherapies. We developed and tested an intervention to improve knowledge and attitudes about naltrexone. A team of researchers, physicians, addiction treatment counselors, and administrators collaborated to develop a naltrexone educational intervention designed for nonmedical addiction professionals. The intervention was compared with a control condition in a pilot study with 6 addiction treatment agencies (3 agencies per group). Participants (counselors and administrators, N = 84) were assessed before and 6 months after the intervention. Results revealed that the intervention significantly improved naltrexone knowledge, and participants who received the intervention reported greater satisfaction with the education they received, as well as greater use of the information. The effect of the intervention on attitudes about naltrexone was encouraging but did not to reach statistical significance. This study is the first reported attempt to develop and test an intervention specifically to improve acceptance of adjunctive medications for alcoholism among nonmedical addiction professionals.
酒精成瘾药物疗法在社区成瘾治疗环境中的使用不足，部分原因是在这些环境中工作的人员——非医学成瘾咨询师和管理人员——缺乏对辅助酒精药物疗法价值的了解和信心。我们开发并测试了一项干预措施，以提高对纳曲酮的认识和态度。一组研究人员、医生、成瘾治疗咨询师和管理人员合作开发了一种针对非医学成瘾专业人员的纳曲酮教育干预措施。在一项针对6家成瘾治疗机构（每组3家机构）的试点研究中，将该干预措施与对照条件进行了比较。在干预前和干预后6个月对参与者（咨询师和管理人员，N = 84）进行了评估。结果显示，该干预措施显著提高了对纳曲酮的认识，接受干预的参与者对所接受的教育更满意，对信息的使用也更多。干预措施对纳曲酮态度方面的影响令人鼓舞，但未达到统计学显著性。本研究是首次报道的专门开发和测试一项干预措施，以提高非医学成瘾专业人员对酒精成瘾辅助药物的接受度。
